Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

48.29
Delayed Data
As of Aug 03
 -0.17 / -0.35%
Today’s Change
22.12
Today|||52-Week Range
52.10
+52.43%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 49.50, with a high estimate of 60.00 and a low estimate of 36.00. The median estimate represents a +2.51% increase from the last price of 48.29.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.36
Sales
$200.4M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 295.08%
 
 
 
 
 
 
Growthannually 6.69%
 
 
 
 
 
 

Sales

Growthquarterly 40.03%
 
 
 
 
 
 
Growthannually 31.74%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.